Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 3,125 shares of Trupanion stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $25.34, for a total transaction of $79,187.50. Following the sale, the senior vice president now directly owns 19,830 shares of the company’s stock, valued at $502,492.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Trupanion Trading Up 1.0 %
Shares of TRUP stock traded up $0.26 during mid-day trading on Friday, reaching $25.13. The stock had a trading volume of 104,059 shares, compared to its average volume of 692,214. The firm has a market capitalization of $1.06 billion, a PE ratio of -38.86 and a beta of 1.76. The stock’s 50-day moving average price is $25.39 and its two-hundred day moving average price is $26.68. The company has a current ratio of 1.62, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion, Inc. has a 52-week low of $18.45 and a 52-week high of $36.66.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02. The company had revenue of $306.12 million for the quarter, compared to the consensus estimate of $300.51 million. Trupanion had a negative return on equity of 9.03% and a negative net margin of 2.31%. Trupanion’s revenue was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.60) EPS. Equities analysts expect that Trupanion, Inc. will post -0.43 earnings per share for the current fiscal year.
Institutional Trading of Trupanion
Analysts Set New Price Targets
Several brokerages have issued reports on TRUP. Piper Sandler dropped their price target on Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. Stifel Nicolaus upped their price objective on shares of Trupanion from $25.00 to $28.00 and gave the company a “hold” rating in a research note on Friday, February 16th. Evercore ISI decreased their target price on shares of Trupanion from $35.00 to $31.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 20th. Finally, Canaccord Genuity Group reduced their price objective on Trupanion from $40.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, May 3rd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $28.75.
Check Out Our Latest Stock Analysis on TRUP
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
- Five stocks we like better than Trupanion
- What is the Australian Securities Exchange (ASX)
- Unity Software’s Mixed Q1, But Long-Term Outlook Remains Positive
- How to Most Effectively Use the MarketBeat Earnings Screener
- JFrog Stock Gets Punished for Solid Results: Buy the Dip
- What is MarketRank™? How to Use it
- Will the Surge in GameStop Stock Spark a New Meme Craze?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.